Pain in Parkinson's disease: Pathology to treatment, medication to deep brain stimulation

NeuroRehabilitation

Volumn 20, Issue 4, 2005, Pages 335-341

  Drake, David F ^a,d   Harkins, Steve ^b   Qutubuddin, Abu ^c  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Box 2800 ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; BOTULINUM TOXIN; CARBIDOPA PLUS LEVODOPA; DOPAMINE; LEVODOPA;

BRAIN DEPTH STIMULATION; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL RESEARCH; FUNCTIONAL ANATOMY; HUMAN; PAIN; PARKINSON DISEASE; REVIEW;

EID: 29744440474     PISSN: 10538135     EISSN: None     Source Type: Journal    
DOI: 10.3233/nre-2005-20408     Document Type: Review

References (60)

1. Y. Aiko, F. Shima, S. Hosokawa, M. Kato and K. Kitamura, Altered local cerebral glucose utilization induced by electrical stimulations of the thalamic sensory and parafascicular nuclei in rats, Brain Res 408 (1987), 47-56.
2. S. Barasi, Responses of substantia nigra neurons to noxious stimulation, Brain Res 171 (1979), 121-130.
3. A.A. Baumeister, T.G. Anticich, M.F. Hawkins, J.C. Liter, H.F. Thibodeaux and E.C. Guillory, Brain Res 447(1) (26 April 1988), 116-121.
4. A.A. Baumeister, M.F. Hawkins, T.G. Anticich, L.L. Moore and T.D. Higgins, Brain Res 411(1) (12 May 1987), 183-186.
5. A.A. Baumeister, M. Nagy, G. Hebert, M.F. Hawkins, A. Vaughn and M.O. Chatellier, Further studies of the effects of intranigral morphine on behavioral responses to noxious stimuli, Brain Res 525(1) (13 Aug 1990), 115-125.
6. B. Bejjani, P. Damier, I. Arnulf, A.M. Bonnet, M. Vidailhet, D. Dormont, B. Pidoux, P. Cornu, C. Marsault and Y. Agid, Pallidal stimulation for Parkinson's disease. Two targets? Neurology 49 (1997), 1564-1569.
7. A.L. Benabid, A. Benazzouz, D. Hoffmann, P. Limousin, P. Krack and P. Pollak, Long-term electrical inhibition of deep brain targets in movement disorders, Mov Disord 13(Suppl 3) (1998), 119-125.
8. A.L. Benabid, S.J. Henriksen, J.F. McGinty and F.F. Bloom, Thalamic nucleus ventro-postero-lateralis inhibits nucleus parafascicularis response to noxious stimuli through a non-opioid pathway, Brain Res 280 (1983), 217-231.
9. A. Benazzouz and M. Hallet, Mechanism of action of deep brain stimulation, Neurology 55(Supp 6) (2000), S13-S16.
10. D. Berg, G. Becker and K. Reiner, Reduction of dyskinesia and induction of akinesia induced by morphine in two parkinsonian patients with severe sciatica, J Neural Transm 106(7-8) (1999), 725-728.
11. R. Cantello, M. Aguggia, M. Gilli, M. Delsedime, A. Riccio, I. Rainero and R. Mutani, Analgesic action of methylphenidate on parkinsonian sensory symptoms. Mechanisms and pathophysiology implications, Arch Neurol 45(9) (Sep 1988), 973-976.
12. J.M. Charcot, Lectures on the Diseases of the Nervous System, (Vol. 1) (translated by G. Sigerson), New Sydenham Society, 1877, 147.
13. E.H. Chudler and W.K. Dong, The role of the basal ganglia in nociception and pain, Pain 60(1) (Jan 1995), 3-38.
14. A.D. Craig, E.M. Reiman, A. Evans and M.C. Bushnell, Functional imaging of an illusion of pain, Nature 384 (1996), 258-260.
15. K.D. Davis, E. Taub, F. Duffner, A.M. Lozano, R.R. Tasker, S. Houle and J.O. Dostrovsky, Activation of the anterior cingulated cortex by thalamic stimulation in patients with chronic pain: a positron emission tomography study, J Neurosurg 92 (2000), 64-69.
16. R. Djaldetti, A. Shifrin, Z. Rogowski, E. Sprecher, E. Melamed and D. Yarnitsky, Quantitative measurement of pain sensation in patients with Parkinson disease, Neurology 62 (2004), 2171-2175.
17. G.H. Duncan, M.C. Bushnell and S. Marchand, Deep brain stimulation: a review of basic research and clinical studies, Pain 45 (1991), 49-59.
18. M. Ertas, A. Sagduyu, N. Arac, B. Uludag and C. Artekin, Use of levodopa to relieve pain from painful symmetrical diabetic polyneuropathy, Pain 75(2-3) (April 1998), 257-259.
19. K.D. Gerhart, R.P. Yezierski, Z.R. Fang and W.D. Willis, Inhibition of primate spinothalamic tract neurons by stimulation in ventral posterior lateral (VPLc) thalamic nucleus: possible mechanisms, J Neurophys. 49 (1983), 406-423.
20. K.D. Gerhart, R.P. Yezierski, T.K. Wilcox, A.E. Grossman and W.D. Willis, Inhibition of primate spinothalamic tract neurons by stimulation in ipsilateral or contralateral ventral posterior lateral (VPLc) thalamic nucleus, Brain Res 229 (1981), 514-519.
21. C. Goetz, C. Tanner, M. Levy, R.S. Wilson and D.C. Garron, Pain in Parkinson's Disease, Mov Disord 1 (1986), 45-49.
22. R. Grant and P. Behan, Resistant thalamic pain treated by levodopa, Brit Med J 289 (1984), 1272.
23. M. Hallett, I. Litvan and the Task Force on Surgery for Parkinson's Disease, Evaluation of surgery for Parkinson's disease, Neurology 53 (1999), 1910-1921.
24. Y. Iribe, K. Moore, K.C. Pang and J.M. Tepper, Subthalamic stimulation-induced synaptic responses in substantia nigra pars compacta dopaminergic neurons in vitro, J Neurophysiol 82 (1992), 925-933.
25. S. Kernbaum and J. Hauchecorne, Administration of levodopa for relief of herpes zoster pain, JAMA 246(2) (10 July 1981), 132-134.
26. W. Koller, R. Pahwa and K. Busenbark, High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor, Ann Neurol 42 (1997), 292-299.
27. W.C. Koller, Sensory symptoms in Parkinson's disease, Neurology 34 (1984), 957-959.
28. P. Krack, P. Pollak, P. Limousin, D. Hoffmann, A. Benazzouz and A.L. Benabid, Inhibition of levodopa effect by internal pallidal stimulation, Mov Disord 13 (1998), 648-652.
29. K. Kumar, C. Toth and R.K. Nath, Deep brain stimulation for intractable pain: a 15-year experience, Neurosurgery 40 (1997), 736-746.
30. K. Kumar, G.M. Wyant and R. Nath, Deep brain stimulation for control of intractable pain in humans, present and future: a ten-year follow-up, Neurosurgery 26 (1990), 774-781.
31. R. Kumar, A. Lozano, Y.J. Kim et al., Double blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease, Neurology 51 (1998), 850-855.
32. R.M. Levy, S. Lamb and J.E. Adams, Treatment of chronic pain by deep brain stimulation: long term follow-up and review of the literature, 21 (1987), 885-893.
33. J. Li, Y.P. Ji, J.T. Qiao and N. Dafny, suppression of nociceptive responses in parafascicular neurons by stimulation of substantia nigra: an analysis of related inhibitory pathways, Brain Res 591(1) (18 Sep 1992), 109-115.
34. P. Limousin, P. Krack, P. Pollack, A. Benazzouz, C. Ardouin, D. Hoffmann and A.L. Benabid, Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease, NEJM 339 (1998), 1105-1111.
35. M.T. Lin, J.J. Wu, A. Chandra and B.L. Tsay, Activation of striatal dopamine receptors induces pain inhibition in rats, J. Neural Transm 51 (1981), 213-222.
36. O. Lindvall, A. Bjorklund and G. Skagerberg, Dopamine-containing neurons in the spinal cord: anatomy and some functional aspects, Ann Neurol. 14 (1983), 255-260.
37. K. Matsubara, S. Fukushima, A. Akane, S. Kobayashi and H. Shoino, Increased urinary morphine, codeine and tetrahydropapaveraline in parkinsonian patients undergoing L-3,4-dihydroxyphenylalanine therapy: a possible biosynthetic pathway of morphine form L-3,4-dihydroxyphenylalanine in humans, J Pharmacol Exp Ther 260(3) (March 1992), 974-978.
38. G.J. Mazars, Intermittent stimulation of nucleus ventralis posterolateralis for intractable pain, Surg Neurol 4 (1975), 93-95.
39. A. Mendlin, F.J. Martin and B.L. Jacobs, Dopaminergic input is required for increases in serotonin output produced by behavioral activation: an in vivo microdialysis study in rat forebrain, Neuroscience 93(3) (1999), 897-905.
40. D.W. Nixon, Use of L-DOPA to relieve pain from bone metastases, NEJM 292 (1975), 647.
41. J.G. Nutt and J.H. Carter, Sensory symptoms in parkinsonism related to central dopaminergic function, Lancet ii (1984), 456-457.
42. C.W. Olanow, M.F. Brin and J.A. Obeso, The role of deep brain stimulation as a surgical treatment for Parkinson's disease, Neurology 55(Suppl 6) (2000), S60-S66.
43. G.H. Paalzow, L-dopa induces opposing effects on pain in intact rats: (-)-sulpiride, SCH 23390 or alpha-methyl-DL-p-tyrosine methylester hydrochloride reveals profound hyperalgesia in large antinociceptive doses, J Pharmacol Exp Ther 263(2) (Nov 1992), 470-479.
44. C. Panchetti, G. Albani, E. Martignoni, L. Godi, E. Alfonsi and G. Nappi, "Off" painful dystonia in Parkinson's disease treated with botulinum toxin, Mov Disord 10(3) (May 1995), 333-336.
45. P. Rainville, G.H. Duncan, D.D. Price, B. Carrier and M.C. Bushnell, Pain affect encoded in human anterior cingulated but not somatosensory cortex, Science 277 (1997), 968-971.
46. P.G. Reum, W. Meissner, A. Marburger et al., High frequency stimulation of the subthalamic nucleus influences striatal dopaminergic metabolism in native rats, Neuro Report 11 (2000), 441-444.
47. D.E. Richardson, Deep brain stimulation for the relief of chronic pain, Neurosurg Clin N Am 6 (1995), 135-144.
48. N.E. Saad, S.F. Atweh, N.B. Bahuth and S.J. Jabbur, Augmentation of nociceptive reflexes and chronic deafferentation pain by chemical lesions of either dopaminergic terminals or midbrain dopaminergic neurons, Brain Res 751(1) (14 March 1997), 1-12.
49. J.I. Sage, H.I. Kortis and W. Sommer, Evidence for the role of spinal cord systems in Parkinson's disease-associated pain, Clin Neuropharmacol 13(2) (April 1990), 171-174.
50. R. Sandyk, Anticholinergic-induced analgesia: possible role for the cholinergic system in abnormal sensory symptoms in Parkinson's disease, Postgrad Med J 62(730) (Aug 1986), 749-751.
51. P.R. Schurrman, D.A. Bosch and P.M. Bossuyt, A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor, NEJM 342 (2000), 462-468.
52. B. Scott, A. Borgman, H. Engler, B. Johnels and S.M. Aquilonius, Gender differences in Parkinson's disease symptom profile, Acta Neurol Scand 102 (2000), 37-43.
53. S.R. Snider, S. Fahn, W.P. Isgreen and L.J. Cote, Primary sensory symptoms in parkinsonism, Neurology 26 (1976), 423-429.
54. T. Taira, H. Kawamura and K. Takakura, Posterior occipital approach in deep brain stimulation for both pain and involuntary movement, Stereotact Funct Neurosurg 70 (1998), 52-56.
55. H. Taquet, F. Javoy-Agid, F. Cesselin and Y. Agid, Methionine-enkephalin deficiency in brains of patients with Parkinson's disease, Lancet I (1981), 1367-1368.
56. M. Thompson and M. Bones, Nontraditional analgesics for the management of postherpetic neuroalgia, Clin Pharm 4(2) (March-April 1985), 170-176.
57. K. Urakami, K. Takahashi, E. Matsushima, K. Sano, S. Nishikawa and T. Takao, The threshold of pain an neurotransmitter's change on pain in Parkinson's disease, Jpn J Psych Neuro 44(3) (1990), 589-593.
58. R.G. Wenzel, Pharmacology of botulinum neurotoxin serotype A, Am J Health Syst Pharm 61(22 Suppl 6) (15 Nov. 2004), S5-S10.
59. F. Windels, N. Bruet, A. Poupard et al., Effects of high frequency stimulation of subthalamic nucleus on extracellular glutamate and GABA in substantia nigra and globus pallidus in the normal rats, Eur J Neurosci 12 (2000), 4141-4146.
60. R.F. Young, F.W. Bach, A.S. Van Norman and T.L. Yaksh, Release of beta-endorphin and methionin-enkephalin into cerebrospinal fluid during deep brain stimulation for chronic pain. Effects of stimulation locus and site of sampling, J Neurosurg 79 (1993), 816-825.